Karrie Wong
![Karrie Wong Karrie Wong](https://til-therapies.com/wp-content/uploads/sites/262/2024/05/Karrie-Wong-Speaker-150x150.png)
Company: KSQ Therapeautics
Job title: Senior Director & Head of Cell Therapy
Seminars:
eTIL: Enhancing Anti-Tumor Function through CRISPR/Cas9 Gene Editing 11:30 am
Immune CRISPRomics Platform discovered SOCS1 and Regnase-1 as top gene targets enhancing T-cell anti-tumor function KSQ-001EX and KSQ-004EX are single and dual-edited engineered TIL (eTIL) products with inactivation of SOCS1 and Regnase-1Read more
day: Conference Day One - Track A - AM